Drug
Leo 19123
Leo 19123: highest development phase Phase 2, developed by LEO Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- LEO Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| LEO 19123 Cream (calcipotriol plus LEO 80122) NCT00764751 | Phase 2 | Psoriasis Vulgaris |
Latest
No recent events.
Follow Leo 19123 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.